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Abstract
Transcriptional repressor DREAM, an EF-hand containing calcium-binding protein, blocks basal expression of target
genes through specific interaction with DRE sites in the DNA. The sequence GTCA forms the central core of the DRE site,
whereas flanking nucleotides contribute notably to the affinity for DREAM. Release of binding of DREAM from the DRE
results in derepression, a process that is regulated by Ca2. Change of two amino acids within an EF-hand in DREAM
blocks Ca2-induced derepression and results in potent dominant negative mutants of endogenous DREAM. ß 2000
Elsevier Science B.V. All rights reserved.
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1. Mechanisms of Ca2+-regulated gene expression
The increase in intracellular calcium as a conse-
quence of membrane depolarization or mobilization
from intracellular stores elicits profound changes in
gene expression [1,2]. The study of the molecular
mechanisms by which Ca2 governs gene expression
was facilitated by the discovery of the Ca2-depen-
dent inducibility of immediate early genes, since this
provided a direct link between the calcium signal and
the e¡ect on transcription [3]. The use of this model
helped to de¢ne the existence of several cellular cas-
cades of kinases and phosphatases that transduce the
calcium signal into changes in the phosphorylation
state of key transcription factors, eventually respon-
sible for changes in gene expression [4^6]. Further-
more, it was also possible to show that the source,
location and extent of the calcium increase in£uence
phosphorylation-dependent gene activation by Ca2.
Thus, rise in cytosolic Ca2 levels following activa-
tion of voltage-sensitive calcium channels, speci¢cally
regulates MAPK-mediated TCF-dependent tran-
scription at the SRE site in the c-fos promoter [7^
9]. In contrast, CREB-mediated c-fos activation at
the CRE site requires a substantial increase in nu-
clear calcium [8]. Moreover, it has been recently
shown that the spike frequency of Ca2 waves
dramatically determines not only the extent of the
inductive e¡ect, but also the set of target genes acti-
vated. Rapid oscillations stimulate the proin£amma-
tory transcription factors NF-AT, Oct/OAP and
NF-UB, whereas infrequent oscillations activate
only NF-UB [10]. This most likely has important
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physiological consequences since downstream target
genes, e.g., interleukin-2 and interleukin-8, will then
be di¡erentially regulated [10].
More recently, two new mechanisms not directly
dependent of kinase and phosphatase activation have
been proposed to participate in Ca2-dependent gene
expression. One relies on a direct interaction between
Ca2-loaded calmodulin or S-100 Ca2-binding pro-
teins and transcription factors of the basic helix^
loop^helix (bHLH) class [11,12]. Upon binding to
these Ca2-loaded complexes, bHLH transcription
factors fail to bind their targets in DNA and
bHLH-dependent transcription is impaired [11^14].
Since bHLH proteins are important determinants
of cell fate during development and cell cycle pro-
gression, Ca2-mediated repression of bHLH may
have a functional role during these processes [15].
Finally, the other new mechanism of Ca2-induced
gene expression involves the newly reported
DREAM protein [16].
2. The DREAM protein
DREAM is a Ca2-binding protein belonging to
the recoverin subfamily of Ca2-binding proteins
[16]. It contains four EF-hands, three of which con-
form to the EF-hand consensus sequence [17], and
binds calcium in vitro shifting the £uorescence emis-
sion spectra due to tryptophan residues. The most
exciting feature of this new calcium-binding protein
is its capacity to bind to a speci¢c sequence in the
DNA, the downstream regulatory element (DRE) in
a Ca2-dependent manner [16,18]. DREAM was
cloned in the search for nuclear proteins that interact
with an oligonucleotide containing the DRE se-
quence from the human prodynorphin gene [16].
Binding of DREAM to the DRE in basal conditions
results in transcriptional repression. Upon Ca2
stimulation, DREAM detaches from the DRE and
transcription is derepressed [16]. This provides a new
mechanism of Ca2-dependent gene expression in
which a calcium sensor directly binds to DNA and
regulates the transcription process as a function of
the nuclear calcium concentration. Furthermore, re-
cent studies have shown that the binding of DREAM
to DRE sites is regulated also by speci¢c protein^
protein interactions with nuclear e¡ectors of the
cAMP pathway [19]. Interestingly, these interactions
are independent of the levels of nuclear Ca2, indi-
cating that transcriptional derepression at DRE sites
can be separately achieved through at least two dis-
tinct signaling pathways; calcium and cAMP activa-
tion. Since cellular stimulation by hormones or acti-
vation of membrane receptors is often followed by a
concomitant elevation in intracellular calcium and
cAMP, both mechanisms can cooperatively derepress
DRE-dependent transcription. Future studies em-
ploying transgenic mice overexpressing DREAM
mutants insensitive to Ca2, to cAMP or to both
stimuli will help to de¢ne the relative weight of
each pathway in DREAM-dependent transcriptional
derepression in vivo.
Expression of DREAM mRNA has been observed
in the CNS, thyroid gland, immune organs and testis
[16]. Surprisingly, when we analyzed its subcellular
distribution we found important levels of DREAM-
binding activity in nuclear-free cytosolic extracts
from HEK 293 cells stably transfected with a
DREAM expression vector [16] or from NB69 cells,
a human neuroblastoma that has endogenous expres-
sion of DREAM [18]. These results suggested that
DREAM might have other functions in the cytosol.
More recently, other groups have con¢rmed the cy-
tosolic location of DREAM, disclosing at the same
time new functions for DREAM outside the nucleus
[20,21]. Using a yeast two-hybrid screening a protein
named calsenilin, which is identical to DREAM, was
found to interact with the carboxy terminal region of
presenilin-2 [20]. However, mutants of calsenilin were
not described in this study and a possible regulation
of the interaction with presenilin-2 by calcium or
cAMP activation remains to be analyzed. Moreover,
three new proteins related to DREAM, named
KchIP (potassium channel interacting protein)31 to
-3, were found also by a two-hybrid screening to
interact with the amino terminal domain of Kv4.2
potassium channels [21]. One of them, KchIP-3, is
identical to DREAM and the interaction with the
Kv4 potassium channels modulates A-type potassi-
um currents in a Ca2-dependent manner [21]. Nota-
bly, the interaction with the potassium channel oc-
curs whether calcium is present or not. However, the
change in KchIP-3/DREAM conformation that fol-
lows binding to Ca2 profoundly a¡ects channel
properties [21]. Noteworthy, A-type potassium cur-
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rents are also modulated by cAMP although the
mechanism has remained elusive [22]. Taken togeth-
er, these results indicate that DREAM/KchIP-3/cal-
senilin might have pleiotropic functions through the
interaction with speci¢c DNA sequences and/or with
proteins in di¡erent cell compartments [16,19^21].
Dual location, nuclear and cytosolic, and multifunc-
tionality, with speci¢c functions in each compart-
ment, are properties previously described for calmod-
ulin, another Ca2-binding protein. It has been
shown that calmodulin interacts with slow-desensitiz-
ing voltage-dependent potassium channels (SK) in
the cell membrane and modulates their permeability
[23], controls the activity of many cytosolic enzymes
(reviewed in [24,25]) and regulates transcription upon
binding to bHLH nucleoproteins [11] and CaM-de-
pendent kinases in the nucleus [4^6, 26]. However,
unlike DREAM, calmodulin does not directly regu-
late transcription since calmodulin binding to DNA
has not been demonstrated.
The capacity to bind DRE sites in the DNA makes
DREAM so far unique and opens the possibility that
there exist other DNA targets for interaction with
EF-hand containing proteins. In addition, the search
for additional genes containing the DRE sequence
that could be targets for DREAM repression/dere-
pression following changes in Ca2 levels awaits a
more de¢nite DRE consensus sequence.
3. The target DRE sequence
The initial DRE sequence was found in the course
of our studies on the regulatory mechanisms control-
ling the expression of the human prodynorphin pro-
moter [18]. By deletion analysis of the human prody-
Fig. 1. Induction of the human prodynorphin promoter by calcium. (A) Schematic representation of the deletion fragments of the hu-
man prodynorphin promoter used in this study. The names of the corresponding reporter plasmids is shown to the right. Position of
the DRE site is shown. (B,C) Transient transfection experiments in NB69 human neuroblastoma cells. Relative CAT activity of the
di¡erent reporter vectors following treatment with 10 mM ca¡eine for 6 h. Each value represents the ratio between the CAT activity
after ca¡eine and the basal CAT activity (B). Mutation of the DRE (G to A within the GTCA core) in reporter pHD1mDRECAT in-
creases its basal activity and prevents further inducibility by calcium (C).
BBAMCR 14676 27-11-00
F. Ledo et al. / Biochimica et Biophysica Acta 1498 (2000) 162^168164
norphin gene we de¢ned a regulatory element located
within the ¢rst exon in the 5P untranslated region
that seemed to be critical for basal and PKA-depen-
dent expression of this gene in several human neuro-
blastoma cell lines [18]. Similarly, Ca2-dependent
expression of the human prodynorphin promoter
was also regulated by the DRE sequence (Fig. 1).
The presence of the DRE was necessary for the in-
ducibility of the reporters after intracellular calcium
release by ca¡eine treatment [27] (Fig. 1B), and mu-
tation of the DRE derepressed transcription, increas-
ing basal CAT activity to the level of activity ob-
served after calcium stimulation in the wild-type
promoter (Fig. 1C). The derepression of DREAM
by ca¡eine is related to the release of Ca2 since it
was mimicked by ionomycin or elevated extracellular
K, treatments that increase intracellular Ca2 con-
centrations, and it was blocked by thapsigargin and
ryanodine, drugs that block intracellular Ca2 release
[16,28]. Moreover, derepression by ca¡eine is not re-
lated to phosphodiesterase inhibition and subsequent
increase in cAMP since direct PKA activation by
forskolin failed to a¡ect the repression of pTKDRE-
CAT by DREAM in HEK293 cells [16]. Further-
more, it was observed that the DRE element
functions as a position-dependent, orientation-inde-
pendent regulatory element that repressed transcrip-
tion even when inserted in heterologous promoters.
Importantly, the DRE functions only when located
downstream from the TATA box [18], the sequence
where the transcription initiation complex assembles
to start the transcription of the gene. Because of this,
the new regulatory element was named as down-
stream regulatory element (DRE). To outline a con-
sensus DRE sequence, we performed serial substitu-
tions to de¢ne key residues within the human
prodynorphin DRE sequence (hDynDRE). First, a
series of hDynDRE mutants in which two nucleo-
tides at a time were replaced by two adenosine resi-
dues was created. These mutants were then analyzed
for their capacity to compete the DRE retarded band
obtained with the hDynDRE probe and nuclear ex-
tracts from NB69 human neuroblastoma cells [18].
As a result, a central core of the DRE element was
proposed containing the GTCA sequence [18]. More-
over, these studies pointed out the importance of the
G residue in the DRE core. Recently, to analyze in
more detail the DRE consensus sequence, we used
recombinant DREAM protein in EMSA using as
probes these mutants as well as new single nucleotide
mutants. We then compared the intensity of the dif-
ferent DRE retarded bands with the DRE band ob-
tained with the hDynDRE oligonucleotide. Single
nucleotide mutations within the GTCA core in
hDynDRE mutants 1^5 disrupted to a great extent
the binding to the DREAM protein (Table 1), as
predicted from previous results [18]. Interestingly,
the most striking loss of binding (more than 85%)
was observed with mutant oligonucleotide 5 bearing
an A to T substitution while an A to C substitution
(mutant 4) still retained 28% of activity compared
with the wild-type hDynDRE sequence (Table 1).
Double substitution within the GTCA core resulting
in mutants 6 to 8 showed very poor capacity to bind
DREAM (Table 1). Comparison of hDynDRE with
the DynDRE from the rat prodynorphin promoter
showed an even greater capacity of rDynDRE to
bind DREAM than hDynDRE (Table 1). Compared
to hDynDRE, the rDynDRE contains numerous
substitutions outside the central GTCA core. Thus,
its higher a⁄nity for DREAM con¢rms the £exibility
of the DRE sequence in the £anking regions outside
the central core, as previously suggested [16,18]. Fur-
thermore, initial search in DNA data bases for the
presence of DRE sequences in regulatory regions
downstream from the TATA box of genes known
to be regulated by calcium ions identi¢ed an inverted
DRE sequence within the 5P untranslated region of
the human c-fos gene [16]. This inverted c-fos DRE
sequence binds recombinant DREAM in vitro and
mediates DREAM-dependent repression of the c-





Mut1 hDynDRE 5P-CCGGAATCAAGGAGGCC-3P 34%
Mut2 hDynDRE 5P-CCGGAGACAAGGAGGCC-3P 27%
Mut3 hDynDRE 5P-CCGGAGTGAAGGAGGCC-3P 36%
Mut4 hDynDRE 5P-CCGGAGTCCAGGAGGCC-3P 28%
Mut5 hDynDRE 5P-CCGGAGTCTAGGAGGCC-3P 14%
Mut6 hDynDRE 5P-CCGGAATAAAGGAGGCC-3P 16%
Mut7 hDynDRE 5P-CCGGAGCTAAGGAGGCC-3P 15%
Mut8 hDynDRE 5P-CCGGATGCAAGGAGGCC-3P 10%
ratDynDRE 5P-CTAGCGTCAGGGCTCCT-3P 130%
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Interestingly, a second inverted DRE sequence was
also observed in the P2 promoter of the CREM gene
(Link et al., in preparation). The P2 promoter con-
trols the calcium- and cAMP-inducible expression of
transcriptional repressor ICER isoforms [29]. In vitro
analysis as well as transient transfection experiments
con¢rmed the functionality of the ICER DRE site
(Link et al., in preparation). Surprisingly, analysis
of these two inverted DRE sequences showed in
both cases a greater a⁄nity for the DREAM protein
than hDynDRE in band shift experiments (Table 2).
However, analysis of an oligonucleotide containing
the hDynDRE sequence synthesized in the inverted
orientation had an a⁄nity for DREAM similar to
that of wild-type hDynDRE (Table 2). These results
indicate that the central core 5P-GTCA-3P can func-
tion also in the inverted, 5P-ACTG-3P, arrangement
and that nucleotides £anking the central core are
important determinants of the a⁄nity for DREAM.
Disclosure of new bona ¢de target genes for
DREAM regulation in vivo using chromatin immu-
noprecipitation will undoubtedly help to delineate
the contribution of nucleotides £anking the DRE
core in the DREAM^DRE interaction.
4. Targeting endogenous DREAM function with
dominant negative mutants
Analysis of DREAM mutants insensitive to calci-
um stimulation showed that substitution of two ami-
no acids at a single functional EF-hand was enough
to prevent Ca2-induced unbinding from the DRE
and derepression [16]. Furthermore, the e¡ect of
the single EF-hand mutation was maximal and no
further e¡ect could be observed when compared
with DREAM mutants in which two or even all
three functional EF-hands were mutated (Fig. 2).
These results suggest that the conformational change
of the DREAM protein that prevents binding to the
DRE following binding to Ca2 requires the coordi-
nated change at each individual EF-hand. Since
cross-linking and southwestern analysis have indi-
cated that DREAM binds to DRE sites as a tetramer
[16,18], we wanted to check whether DREAM mu-
tants insensitive to Ca2 could behave as dominant
negative mutants for Ca2 stimulation in a back-
ground of endogenous DREAM protein. To test
this hypothesis we analyzed the DRE-dependent de-
repression after ca¡eine stimulation in the presence
of di¡erent combinations of wild-type DREAM and
EF-hand DREAM mutant. The experiments were
performed in HEK293 cells, which lack endogenous
expression of DREAM, and we used the triple EF-
hand DREAM mutant which has substitutions in all
three functional EF-hands (234EFmutDREAM). A
reporter plasmid containing the minimal promoter
of the human prodynorphin gene including the
DRE site (pHD3CAT) [18] was used in these experi-
ments. Exposure to ca¡eine induced a 6-fold increase
of the pHD3CAT reporter. Cotransfection with the
wild-type DREAM expression vector did no a¡ect
the induction after ca¡eine while cotransfection
with mutant DREAM almost completely blocked
the induction after ca¡eine (Fig. 3), in keeping with








Reverse hDynDRE 5P-CCGGAGGAACTGAGGCC-3P 97%
Fig. 2. Derepression by calcium stimulation of DRE-dependent
transcription is blocked in the presence of EF-hand mutants of
DREAM. DREAM (black bar) and single, double or triple
DREAM mutants insensitive to calcium (EFmDREAM,
hatched bars) repress to a similar extent basal activity of DRE-
containing reporter pTKDRECAT in HEK293 human carcino-
ma cells. Exposure to 10 mM ca¡eine blocks the repression of
pTKDRECAT activity by DREAM (black bar) but does not
a¡ect repression by EFmDREAM mutants (hatched bars).
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transfection with 234EFmutDREAM and
wtDREAM in ratios 1:1, 1:2 and 1:3 did not signi¢-
cantly change the blockade observed with 234EF-
mutDREAM alone. Interestingly, the e¡ect of caf-
feine was partially recovered after cotransfection
with 234EFmutDREAM and wtDREAM in a ratio
1:6 and the e¡ect of the DREAM mutant was negli-
gible at ratios equal or higher than 1:9 with
wtDREAM (Fig. 3). These results support the hy-
pothesis that DREAM binds to the DNA as a multi-
mer and strengthen the notion of a ¢nely tuned reg-
ulation of the DREAM^DRE interaction by calcium
ions. Furthermore, these results indicate that
DREAM mutants insensitive to Ca2 stimulation
are dominant negative mutants of Ca2-regulated
DREAM function.
5. Concluding remarks
The discovery of DREAM has initiated a new
avenue of research for other calcium sensors able
to directly link changes in the nuclear concentration
of Ca2 with profound e¡ects on gene expression.
Further analysis of the DREAM protein revealing
(i) the amino acids that compose the DNA-binding
domain, (ii) the region that participates in the oligo-
merization of DREAM and (iii) the molecular mech-
anism of the transcriptional repression by DREAM,
should promptly clarify several fundamental aspects
of DREAM function in the nucleus. Moreover, stud-
ies using DREAM as the bait in a yeast two-hybrid
screen could disclose new protein^protein interac-
tions, revealing new functions for the DREAM pro-
tein in the cytosol. Finally, preparation of transgenic
mice targeting the expression of dominant negative
mutants of DREAM to neurons, thymus, sperma-
tides or thyroid gland with tissue-speci¢c promoters
should also shed light on the functional role of
DREAM in vivo.
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